Trial intelligence / Profile preview

Botox Cosmetic for Depressor Anguli Oris

NCT04240535Phase 4Not yet recruiting

Start
Jan 2020
Primary completion
May 2020
Modality
Recombinant Proteins and Enzymes
Countries
1
01

Overview

A Phase 4 trial of botulinum toxin type A in Skin aging. Planned start Jan 2020; status: not yet recruiting.

02

Drugs

botulinum toxin type A
03

Conditions

Skin aging

Beyond the preview

Go deeper on NCT04240535.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT04240535.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call